Literature DB >> 28794197

Hyperalgesia and sensitization of dorsal horn neurons following activation of NK-1 receptors in the rostral ventromedial medulla.

Sergey G Khasabov1, Patrick Malecha1, Joseph Noack1, Janneta Tabakov1, Glenn J Giesler2, Donald A Simone3.   

Abstract

Neurons in the rostral ventromedial medulla (RVM) project to the spinal cord and are involved in descending modulation of pain. Several studies have shown that activation of neurokinin-1 (NK-1) receptors in the RVM produces hyperalgesia, although the underlying mechanisms are not clear. In parallel studies, we compared behavioral measures of hyperalgesia to electrophysiological responses of nociceptive dorsal horn neurons produced by activation of NK-1 receptors in the RVM. Injection of the selective NK-1 receptor agonist Sar9,Met(O2)11-substance P (SSP) into the RVM produced dose-dependent mechanical and heat hyperalgesia that was blocked by coadministration of the selective NK-1 receptor antagonist L-733,060. In electrophysiological studies, responses evoked by mechanical and heat stimuli were obtained from identified high-threshold (HT) and wide dynamic range (WDR) neurons. Injection of SSP into the RVM enhanced responses of WDR neurons, including identified neurons that project to the parabrachial area, to mechanical and heat stimuli. Since intraplantar injection of capsaicin produces robust hyperalgesia and sensitization of nociceptive spinal neurons, we examined whether this sensitization was dependent on NK-1 receptors in the RVM. Pretreatment with L-733,060 into the RVM blocked the sensitization of dorsal horn neurons produced by capsaicin. c-Fos labeling was used to determine the spatial distribution of dorsal horn neurons that were sensitized by NK-1 receptor activation in the RVM. Consistent with our electrophysiological results, administration of SSP into the RVM increased pinch-evoked c-Fos expression in the dorsal horn. It is suggested that targeting this descending pathway may be effective in reducing persistent pain.NEW & NOTEWORTHY It is known that activation of neurokinin-1 (NK-1) receptors in the rostral ventromedial medulla (RVM), a main output area for descending modulation of pain, produces hyperalgesia. Here we show that activation of NK-1 receptors produces hyperalgesia by sensitizing nociceptive dorsal horn neurons. Targeting this pathway at its origin or in the spinal cord may be an effective approach for pain management.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  descending facilitation; electrophysiology; pain; spinal cord

Mesh:

Substances:

Year:  2017        PMID: 28794197      PMCID: PMC5675905          DOI: 10.1152/jn.00478.2017

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  110 in total

1.  Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin.

Authors:  Rie Suzuki; Wahida Rahman; Lars J Rygh; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Pain       Date:  2005-10       Impact factor: 6.961

2.  Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways.

Authors:  Rie Suzuki; Sara Morcuende; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

Review 3.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

Review 4.  Bad news from the brain: descending 5-HT pathways that control spinal pain processing.

Authors:  Rie Suzuki; Lars J Rygh; Anthony H Dickenson
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

5.  Topographic organization of substance P and monoamine cells in the ventral medulla of the cat.

Authors:  L Marson; A D Loewy
Journal:  J Auton Nerv Syst       Date:  1985-11

6.  Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons.

Authors:  D A Simone; L S Sorkin; U Oh; J M Chung; C Owens; R H LaMotte; W D Willis
Journal:  J Neurophysiol       Date:  1991-07       Impact factor: 2.714

7.  Supraspinal glial-neuronal interactions contribute to descending pain facilitation.

Authors:  Feng Wei; Wei Guo; Shiping Zou; Ke Ren; Ronald Dubner
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

Review 8.  Chronic pain and medullary descending facilitation.

Authors:  Frank Porreca; Michael H Ossipov; G F Gebhart
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

9.  Sensitization of lamina I spinoparabrachial neurons parallels heat hyperalgesia in the chronic constriction injury model of neuropathic pain.

Authors:  David Andrew
Journal:  J Physiol       Date:  2009-03-16       Impact factor: 5.182

10.  Parabrachial complex links pain transmission to descending pain modulation.

Authors:  Zachary Roeder; QiLiang Chen; Sophia Davis; Jonathan D Carlson; Domenico Tupone; Mary M Heinricher
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

View more
  10 in total

1.  Neuronal activities in the rostral ventromedial medulla associated with experimental occlusal interference-induced orofacial hyperalgesia.

Authors:  Si-Yi Mo 莫思怡; Xiao-Xiang Xu 徐啸翔; Shan-Shan Bai 白珊珊; Yun Liu 刘云; Kai-Yuan Fu 傅开元; Barry J Sessle; Ye Cao 曹烨; Qiu-Fei Xie 谢秋菲
Journal:  J Neurosci       Date:  2022-06-03       Impact factor: 6.709

2.  Postsurgical Latent Pain Sensitization Is Driven by Descending Serotonergic Facilitation and Masked by µ-Opioid Receptor Constitutive Activity in the Rostral Ventromedial Medulla.

Authors:  Andrew H Cooper; Naomi S Hedden; Pranav Prasoon; Yanmei Qi; Bradley K Taylor
Journal:  J Neurosci       Date:  2022-06-14       Impact factor: 6.709

Review 3.  Shifting the Balance: How Top-Down and Bottom-Up Input Modulate Pain via the Rostral Ventromedial Medulla.

Authors:  Qiliang Chen; Mary M Heinricher
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-28

4.  The nAChR Chaperone TMEM35a (NACHO) Contributes to the Development of Hyperalgesia in Mice.

Authors:  Sergey G Khasabov; Victoria M Rogness; Montana B Beeson; Lucy Vulchanova; Li-Lian Yuan; Donald A Simone; Phu V Tran
Journal:  Neuroscience       Date:  2021-01-07       Impact factor: 3.590

5.  Immediate inhibition of spinal secretory phospholipase A2 prevents the pain and elevated spinal neuronal hyperexcitability and neuroimmune regulatory genes that develop with nerve root compression.

Authors:  Julia C Quindlen-Hotek; Sonia Kartha; Beth A Winkelstein
Journal:  Neuroreport       Date:  2020-10-14       Impact factor: 1.703

6.  Selective Ablation of Descending Serotonin from the Rostral Ventromedial Medulla Unmasks Its Pro-Nociceptive Role in Chemotherapy-Induced Painful Neuropathy.

Authors:  Xijiang Liu; Gongming Wang; Geyi Ai; Xiqiang Xu; Xinhuan Niu; Mengyuan Zhang
Journal:  J Pain Res       Date:  2020-11-24       Impact factor: 3.133

7.  Neurokinin receptor mechanisms in forebrain medial septum modulate nociception in the formalin model of inflammatory pain.

Authors:  Si Yun Ng; Mohammed Zacky Ariffin; Sanjay Khanna
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

8.  Inhibition of itch by neurokinin 1 receptor (Tacr1) -expressing ON cells in the rostral ventromedial medulla in mice.

Authors:  Taylor Follansbee; Dan Domocos; Eileen Nguyen; Amanda Nguyen; Aristea Bountouvas; Lauren Velasquez; Mirela Iodi Carstens; Keiko Takanami; Sarah E Ross; Earl Carstens
Journal:  Elife       Date:  2022-08-16       Impact factor: 8.713

9.  Forebrain medial septum sustains experimental neuropathic pain.

Authors:  Mohammed Zacky Ariffin; Khairunisa Mohamad Ibrahim; Andy Thiam-Huat Lee; Rui Zhi Lee; Shou Yu Poon; Hwai Kit Thong; Eugene Hern Choon Liu; Chian-Ming Low; Sanjay Khanna
Journal:  Sci Rep       Date:  2018-08-08       Impact factor: 4.379

10.  Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.

Authors:  N Ved; M E Da Vitoria Lobo; S M Bestall; C L Vidueira; N Beazley-Long; K Ballmer-Hofer; M Hirashima; D O Bates; L F Donaldson; R P Hulse
Journal:  J Physiol       Date:  2018-07-11       Impact factor: 5.182

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.